Disseminated Intravascular Coagulation: Proceedings of an International Symposium, Tokyo, November 26-28, 1981Takeshi Abe, Manabu Yamanaka |
Contents
A Coopera | 15 |
Intravascular Coagulation as a Clinical Manifestation of the Shwartzman Reaction | 41 |
General Discussion | 59 |
Copyright | |
18 other sections not shown
Common terms and phrases
acute anticoagulant antilung antithrombin antithrombin III APL leukocytes aprotinin APTT assay autopsy bleeding blood coagulation capillaries caused cells changes circulating Clin coagulation factors coagulation mechanism concentration criteria damage decrease development of DIC diagnosis of DIC disseminated intravascular coagulation endothelial endotoxin factor VIII FDP level fibrin degradation products fibrin thrombi fibrinogen fibrinogen level fibrinolysis fibrinolytic activity fibrinopeptide formation gastric cancer gastric cancer tissues heparin heparin therapy hepatic homogenates human hypercoagulable increased induced infusion inhibition inhibitor intravascular coagulation DIC Japan kidney Korean hemorrhagic fever laboratory leukemia leukocytes liver lung lysis malignant tumors Medicine mg/dl microthrombi Müller-Berghaus necrosis newborn infants Nossel occurs oleic acid organs pathogenesis pathologically confirmed DIC patients with DIC placenta plasma plasmin platelet count pregnancy prekallikrein procoagulant activity prothrombin pulmonary rabbits renal Shwartzman reaction soluble fibrin syndrome Table thrombin thrombolysis thrombosis tion tissue thromboplastin Tokyo TTP activity underlying diseases vivo